제1형 당뇨병을 동반한 조현병 환자의 총 의료비용 및 입원 위험
A Study of Total Medical Cost and Hospitalization Risk of Patients with Schizophrenia and Type 1 Diabetes Mellitus
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: The aim of this study was to explore the prevalence of type 1 diabetes in patients with schizophrenia and their total medical costs and risk of hospitalization. Methods: This study used Health Insurance Review and Assessment Service data in Korea. To examine total medical costs and risk of hospitalization, we selected 1,510 subjects with schizophrenia (half with and half without type 1 diabetes) that were 1:1 matched via propensity score matching. In health care system perspective, total medical costs included out-of-pocket and insurer’s costs. Logistic regression models were used to examine the risk of hospitalization. Results: The prevalence of type 1 diabetes in patients with schizophrenia was 3.87 per 1,000 person year. Among patients with schizophrenia, the amount of total average medical costs and hospitalization costs in patients with type 1 diabetes was 1.49 and 1.59 times higher than those in patients without it, respectively. The odds of hospitalization were higher among patients with type 1 diabetes compared with those without it (odds ratio, OR=1.97 ; 95% CI 1.60-2.43). Conclusion: This study showed that medical costs and risk of hospitalization were higher in schizophrenia patients with type 1 diabetes. Therefore, these individuals may require specific care programs.
Abstract
Objectives: The aim of this study was to explore the prevalence of type 1 diabetes in patients with schizophrenia and their total medical costs and risk of hospitalization. Methods: This study used Health Insurance Review and Assessment Service data in Korea. To examine total medical costs and risk of hospitalization, we selected 1,510 subjects with schizophrenia (half with and half without type 1 diabetes) that were 1:1 matched via propensity score matching. In health care system perspective, total medical costs included out-of-pocket and insurer’s costs. Logistic regression models were used to examine the risk of hospitalization. Results: The prevalence of type 1 diabetes in patients with schizophrenia was 3.87 per 1,000 person year. Among patients with schizophrenia, the amount of total average medical costs and hospitalization costs in patients with type 1 diabetes was 1.49 and 1.59 times higher than those in patients without it, respectively. The odds of hospitalization were higher among patients with type 1 diabetes compared with those without it (odds ratio, OR=1.97 ; 95% CI 1.60-2.43). Conclusion: This study showed that medical costs and risk of hospitalization were higher in schizophrenia patients with type 1 diabetes. Therefore, these individuals may require specific care programs.
참고문헌 (31)
- Prevention of Mental Disorders: Effective Interventions and Policy Options, "World Health Organization", World Health Organization, 15~16 (2004)
- Bloom D, "The global economic burden of noncommunicable diseases", World Economic Forum, ~ (2012)
- Korea Health Industry Development Industry, "Mental illness sector R & D trends and implications (HT R&D No 2013-006)", ~ (2013)
- 장성만, "Economic Burden of Schizophrenia in South Korea", Journal of Korean Medical Science, 23(2), pp.167~175 (2008), 대한의학회
- Ministry of Health & Welfare, "The epidemiological survey of mental disorders in Korea", ~ (2016)
- Simeone JC, "An evaluation of variation in published estimates of schizophrenia prevalence from 1990-2013: a systematic literature review", BMC Psychiatry, 15, pp.193~ (2015)
- Laursen TM, "Excess early mortality in schizophrenia", Annu Rev Clin Psychol, 10, pp.425~448 (2014)
- Mitchell AJ, "Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis", Schizophr Bull, 39, pp.306~318 (2011)
- Ratliff JC, "Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness", Psychosomatics, 54, pp.67~73 (2013)
- Hert M, "Metabolic syndrome in people with schizophrenia: a review", World Psychiatry, 8, pp.15~22 (2009)
- Stubbs B, "The prevalence and predictors of type two diabetes mellitus in people with schizophrenia:a systematic review and comparative meta-analysis", Acta Psychiatr Scand, 132, pp.144~157 (2015)
- Vancampfort D, "Association of the metabolic syndrome with physical activity performance in patients with schizophrenia", Diabetes Metab, 37, pp.318~323 (2011)
- Nasrallah HA, "Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline", Schizophr Res, 86, pp.15~22 (2006)
- Becker T, "Risk of acute complications of diabetes among people with schizophrenia in Ontario. Canada", Diabetes Care, 34, pp.398~402 (2011)
- Eaton WW, "Association of schizophrenia and autoimmune diseases: linkage of Danish national registers", Am J Psychiatry, 163, pp.521~528 (2006)
- Juvonen H, "Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus", Arch Gen Psychiatry, 64, pp.894~899 (2007)
- Benros ME, "Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study", Am J Psychiatry, 168, pp.1303~1310 (2011)
- Chen SJ, "prevalence of autoimmune diseases in in-patients with schizophrenia:nationwide population-based study", Br J Psychiatry, 200, pp.374~380 (2012)
- Goueslard K, "Increased Risk of Rehospitalization for Acute Diabetes Complications and Suicide Attempts in Patients With Type 1 Diabetes and Comorbid Schizophrenia", Diabetes Care, 41, pp.2316~2321 (2018)
- 김록영, "입원 환자 표본 개발에 관한 연구: 국민건강보험 청구자료를 중심으로", 보건행정학회지, 23(2), pp.152~161 (2013), 한국보건행정학회
- Prevalence of Multimorbidity and Transitional Patterns of Chronic Diseases among Korean Adults, "Jun JA", Korea Institute for Health and Social Affairs, ~ (2014)
- 김창훈, "복합만성질환자의 다빈도 만성질환조합 유형과 질병부담", 보건경제와 정책연구, 20(4), pp.81~102 (2014), 한국보건경제정책학회
- Guo S, "Propensity Score Analysis: Statistical Methods and Applications" (2010), SAGE Publications Inc
- Parsons LS, "Performing a 1:N case-control match on propensity score", Proceedings of the 29th Annual SAS Users Group International Conference (2004), SAS Institute
- Hallford P, "A study of type-1 diabetes associated autoantibodies in schizophrenia", Schizophr Res, 176, pp.186~190 (2016)
- Piette JD, "The impact of comorbid chronic conditions on diabetes care", Diabetes Care, 29, pp.725~731 (2006)
- Harman JS, "The influence of comorbid chronic medical conditions on the adequacy of depression care for older Americans", J Am Geriatr Soc, 53, pp.2178~2183 (2005)
- Yoon J, "Costs associated with multimorbidity among VA patients", Med Care, 52, pp.31~36 (2014)
- "The five year forward view for mental health" (2016)[URL]
- Blixen CE, "Barriers to self-management of serious mental illness and diabetes", Am J Health Behav, 40, pp.194~204 (2016)
- McKibbin CL, "A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial", Schizophr Res, 86, pp.36~44 (2006)